News - USA

1 to 26 of 4763 results

Article
Digital therapeutics company goes public in SPAC merger

Digital therapeutics company goes public in SPAC merger

26-01-2022

In another example of the growing popularity of the SPAC merger, digital medicine company Akili Interactive…

Akili InteractiveBusiness FinancingDigital PharmaEndeavorRxManagement神经系统UKUSA

Article
Kyverna Therapeutics closes $85 million Series B financing

Kyverna Therapeutics closes $85 million Series B financing

26-01-2022

US autoimmune drug developer Kyverna Therapeutics today announced it has closed an oversubscribed $85…

BiotechnologyBusiness FinancingGilead SciencesKYV-101Kyverna TherapeuticsOne to Watch CompaniesResearchUSA

Article
Sierra Oncology soars as momelotinib hits goals in myelofibrosis study

Sierra Oncology soars as momelotinib hits goals in myelofibrosis study

26-01-2022

US biopharma firm Sierra Oncology yesterday announced positive top-line data from the pivotal Phase III…

BiotechnologyDrug TrialHematologymomelotinibMyelofibrosisOncologyOne to Watch CompaniesResearchSierra OncologyUSA

Article
Metagenomi closes oversubscribed $175M Series B financing

Metagenomi closes oversubscribed $175M Series B financing

26-01-2022

我们基因编辑start-up Metagenomi has announced the completion of an up-sized and oversubscribed $175…

AIBiotechnologyBusiness FinancingDigital PharmaMetagenomiUSA

Article
Low-cost checkpoint blocker advances through clinic
Article
Leaps by Bayer leads $80 million Series A financing for Cellino

Leaps by Bayer leads $80 million Series A financing for Cellino

25-01-2022

US cell therapies maker Cellino Biotech has completed a Series A financing of $80 million, led by the…

BayerBiotechnologyBusiness FinancingCell and Gene TherapyCellino BiotechGermanyProductionRegenerative MedicineResearchUSA

Article
Anixa claims drug shows signs of superiority over Paxlovid

Anixa claims drug shows signs of superiority over Paxlovid

25-01-2022

Californian biotech Anixa Biosciences and its partner MolGenie have claimed that they have synthesized…

Anixa生物科学BiotechnologyCoronavirusDrug TrialFocus OnGermanyInfectious diseasesMolGeniePaxlovidPfizerResearchUSA

Article
Merck & Co shares dented by gefapixant CRL

Merck & Co shares dented by gefapixant CRL

25-01-2022

The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck…

Focus OngefapixantMerck & CoPharmaceuticalRegulationRespiratory and PulmonaryUS FDAUSA

Article
FDA limits use of certain MAbs to treat COVID-19

FDA limits use of certain MAbs to treat COVID-19

25-01-2022

As we have throughout the COVID-19 pandemic, the US Food and Drug Administration has used the best available…

bamlanivimabBiotechnologyCoronavirusEli LillyetesevimabInfectious diseasesREGEN-COV2Regeneron PharmaceuticalsRegulationUS FDAUSA

Article
ANI Pharmaceuticals announces commercial availability of Cortrophin Gel

ANI Pharmaceuticals announces commercial availability of Cortrophin Gel

24-01-2022

USA-based generic drugmaker ANI Pharmaceuticals today announced the US commercial availability of Purified…

ANI PharmaceuticalsAnti-Arthritics/RheumaticscorticotropinCortrophin GelGenericsMusculoskeletalProduct LaunchUSA

Article
FDA: The outlook for 2022

FDA: The outlook for 2022

24-01-2022

Since 2020, the US Food and Drug Administration’s activities have centered around the response to the…

AduhelmAll therapy areasBiogenFDA blogFocus OnFrom our correspondentIn DepthLagevrioMerck & CoModernaNovavaxPaxlovidPfizerPharmaceuticalRegulationSpikevaxUS FDAUSA

Article
OPKO dives as FDA issues CRL on somatrogon BLA

OPKO dives as FDA issues CRL on somatrogon BLA

24-01-2022

The US Food and Drug Administration has issued a Complete Response Letter (CRL) for the Biologics License…

BiotechnologyEndocrinologyFocus OnNgenlaOne to Watch CompaniesOPKO HealthPfizerRare diseasesRegulationsomatrogonUS FDAUSA

Article
积极的III期研究vutrisiran的患者with hATTR amyloidosis

积极的III期研究vutrisiran的患者with hATTR amyloidosis

22-01-2022

US RNAi therapeutics company Alnylam Pharmaceuticals’ on Friday revealed new data supporting the case…

Alnylam PharmaceuticalsAmyloidosisBiotechnologyDrug TrialOne to Watch CompaniesRare diseasesResearchUSAvutrisiran

Article
Long-term clinical outcomes with Libmeldy in children with early-onset MLD

Long-term clinical outcomes with Libmeldy in children with early-onset MLD

22-01-2022

Gene therapy developer Orchard Therapeutics has announced the publication in The Lancet of long-term…

BiotechnologyCell and Gene TherapyDrug TrialLibmeldyOne to Watch CompaniesOrchard TherapeuticsResearchUSA

Article
Regulators publish report on vaccines against Omicron

Regulators publish report on vaccines against Omicron

21-01-2022

Global regulators have published a report on the effectiveness of current vaccines against the COVID-19…

CoronavirusEuropeFocus OnInfectious diseasesPharmaceuticalPublic healthRegulationUSAVaccines

Article
Frank Clyburn to quit Merck & Co for CEO role outside pharma

Frank Clyburn to quit Merck & Co for CEO role outside pharma

21-01-2022

Once touted as a potential successor to Merck & Co’s former boss Kenneth Frazier, Frank Clyburn is…

必威体育betway888登录Kenneth FrazierManagementMerck & CoPharmaceuticalUSA

Article
US regulator lifts clinical trial hold on Kura Oncology

US regulator lifts clinical trial hold on Kura Oncology

21-01-2022

The US regulator has cleared San Diegan precision medicine firm Kura Oncology to resume the KOMET-001…

Drug TrialHematologyKO-539Kura OncologyPharmaceuticalRegulationResearchSyndax PharmaceuticalstipifarnibUS FDAUSA

Article
Daiichi Sankyo to divest eight legacy products to Cosette Pharmaceuticals

1 to 26 of 4763 results

Back to top

Baidu